Alta Partners

edit

Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in the industry since 1996. Their diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for their companies and their investors.

Milestones

edit

• 
  Alta Partners invested in Metabolex. (11/5/09)
  Posted 11/9/09 at 3:52pm
• 
  Alta Partners invested in aTyr Pharma. (9/15/09)
  Posted 9/18/09 at 6:01am
• 
  Alta Partners invested in Chimerix. (8/10/09)
  Posted 8/11/09 at 2:23pm
• 
  Alta Partners invested in Calistoga. (6/14/09)
  Posted 6/16/09 at 8:42am
• 
  Alta Partners invested in Avid Radiopharmaceuticals. (5/21/09)
  Posted 6/15/09 at 8:12am
• 
  Alta Partners invested in Calistoga Pharmaceuticals. (5/5/09)
  Posted 7/7/09 at 12:25pm
• 
  Alta Partners invested in Sunesis Pharmaceuticals. (4/7/09)
  Posted 4/12/09 at 11:31am
• 
  Alta Partners invested in Aerovance. (4/7/09)
  Posted 4/10/09 at 8:36am
• 
  Alta Partners invested in Sutro Biopharma. (3/30/09)
  Posted 6/19/09 at 8:40am
• 
  Alta Partners invested in Intradigm Corporation. (1/7/09)
  Posted 6/25/09 at 4:40am
• 
  Alta Partners invested in Xelerated . (8/14/08)
  Posted 7/20/09 at 3:31am
• 
  Alta Partners invested in Sierra Surgical. (7/27/08)
  Posted 9/9/09 at 3:25am
• 
  Alta Partners invested in Vaccsys. (6/20/08)
  Posted 9/10/09 at 10:58pm
• 
  Alta Partners invested in Esperion Therapeutics. (5/1/08)
  Posted 6/3/09 at 10:56pm
• 
  Alta Partners invested in Trevena. (3/08)
  Posted 6/17/09 at 6:23pm
• 
  Alta Partners invested in Taligen Therapeutics. (1/08)
  Posted 6/21/09 at 11:35pm

Investments

Videos

Sources

1. Metabolex (Metabolex.com) [edit]
2. aTyr Pharma, Inc.: Series C $12M (onbiovc.com) [edit]
3. VC insiders inject $16M into Chimerix (fiercebiotech.com) [edit]
4. Calistoga Pharmaceuticals, Inc.: Series B $30M (onbiovc.com) [edit]
5. Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing (avidrp.com) [edit]
6. Capital Report Index [edit]
7. VCs PIPE $43.5 Million to Sunesis Pharma (pehub.com) [edit]
8. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
9. Sutro Biopharma lands $15M with protein production (bizjournals.com) [edit]
10. Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive (fiercebiotech.com) [edit]
11. Xelerated Closes $13 Million Funding Round (xelerated.com) [edit]
12. Sierra Surgical raises $14.5M for female sterilization (deals.venturebeat.com) [edit]
13. Vaccsys raises $9 million for vaccine research (deals.venturebeat.com) [edit]
14. Esperion Therapeutics Completes $22.75M Series A Financing (esperion.com) [edit]
15. Trevena, Inc. Announces $24 Million Series A Financing (trevenainc.com) [edit]
16. Taligen Therapeutics Secures Series B Financing (taligentherapeutics.com) [edit]
17. Fundamental Applied Biology raises $21M for making “cell-free” proteins (deals.venturebeat.com) [edit]
18. Carbylan Announces $20 Million Series B Financing (carbylan.com) [edit]
19. Sierra Surgical raises $7.1M for female-sterilization tech (deals.venturebeat.com) [edit]
20. Paracor raises $44M for heart-failure device that restrains the heart (venturebeat.com) [edit]
21. Alarm:clock (thealarmclock.com) [edit]
22. Metabolex (Metabolex.com) [edit]
23. Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more (deals.venturebeat.com) [edit]
24. Aerovance, asthma treatment company, finishes raising $60M (deals.venturebeat.com) [edit]
25. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
26. Intarcia restarts with $50M for hepatitis, diabetes treatments (deals.venturebeat.com) [edit]
27. Sanuras, breat tumor device company raises $15M (deals.venturebeat.com) [edit]
28. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]